Nymox Pharmaceutical
NYMX
#10304
Rank
A$26.44 M
Marketcap
Country
A$0.29
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.37 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.46 Million, an increase over its 2021 earnings that were of -A$18.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.37 Million-64.37%
2022 -A$9.46 Million-47.71%
2021 -A$18.09 Million6.61%
2020 -A$16.96 Million-10.91%
2019 -A$19.04 Million24.24%
2018 -A$15.33 Million-20.03%
2017 -A$19.16 Million2.71%
2016 -A$18.66 Million-63.86%
2015 -A$51.63 Million674.44%
2014 -A$6.67 Million-6.11%
2013 -A$7.1 Million-35.66%
2012 -A$11.04 Million-20.76%
2011 -A$13.93 Million38.33%
2010 -A$10.07 Million35.59%
2009 -A$7.43 Million11.8%
2008 -A$6.65 Million-12.94%
2007 -A$7.63 Million8.85%
2006 -A$7.01 Million36.5%
2005 -A$5.14 Million-4.4%
2004 -A$5.38 Million-14.58%
2003 -A$6.29 Million
2001 -A$4.62 Million-20.54%
2000 -A$5.81 Million21.72%
1999 -A$4.77 Million-25.56%
1998 -A$6.41 Million101.3%
1997 -A$3.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.60 B-1,552,714.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.76 B-471,733.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.26 B-391,863.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.27 B-1,190,803.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.90 B-61,090.28%๐Ÿ‡บ๐Ÿ‡ธ USA